Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula A Matulonis

Showing results (61-70 of 236) with videos related to

Pageof 24
Sort By:
JCO Precision Oncology|July 25, 2020
Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth K Lee, Katharine M Esselen, David L Kolin, et al.
Journal of Psychosocial Oncology|August 24, 2010
Long-term adjustment of survivors of ovarian cancer treated for advanced-stage diseaseAlice B Kornblith, Kristina Mirabeau-Beale, Hang Lee, et al.
BMC Medicine|August 19, 2020
Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networksKun-Hsing Yu, Vincent Hu, Feiran Wang, et al.
JMIR Cancer|November 15, 2023
Open-Source, Step-Counting Algorithm for Smartphone Data Collected in Clinical and Nonclinical Settings: Algorithm Development and Validation StudyMarcin Straczkiewicz, Nancy L Keating, Embree Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Validation of an open-source smartphone step counting algorithm in clinical and non-clinical settingsMarcin Straczkiewicz, Nancy L Keating, Embree Thompson, et al.
Journal of Pain and Symptom Management|December 27, 2005
Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancerUrsula A Matulonis, Michael V Seiden, Maria Roche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitorEmily S Robinson, Ursula A Matulonis, Percy Ivy, et al.
Gynecologic Oncology|December 9, 2008
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumorsUrsula A Matulonis, Karen J Krag, Carolyn N Krasner, et al.
Gynecologic Oncology|September 6, 2011
Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levelsChristine M Coticchia, Adam S Curatolo, David Zurakowski, et al.
Molecular Cancer Therapeutics|September 8, 2023
FF-10850, a Novel Liposomal Topotecan Achieves Superior Antitumor Activity via Macrophage- and Ammonia-Mediated Payload Release in the Tumor MicroenvironmentSusumu Shimoyama, Ken Okada, Toshifumi Kimura, et al.
Pageof 24

Showing results (61-70 of 236) with videos related to

Sort By:
Pageof 24
JCO Precision Oncology|July 25, 2020
Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth K Lee, Katharine M Esselen, David L Kolin, et al.
Journal of Psychosocial Oncology|August 24, 2010
Long-term adjustment of survivors of ovarian cancer treated for advanced-stage diseaseAlice B Kornblith, Kristina Mirabeau-Beale, Hang Lee, et al.
BMC Medicine|August 19, 2020
Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networksKun-Hsing Yu, Vincent Hu, Feiran Wang, et al.
JMIR Cancer|November 15, 2023
Open-Source, Step-Counting Algorithm for Smartphone Data Collected in Clinical and Nonclinical Settings: Algorithm Development and Validation StudyMarcin Straczkiewicz, Nancy L Keating, Embree Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Validation of an open-source smartphone step counting algorithm in clinical and non-clinical settingsMarcin Straczkiewicz, Nancy L Keating, Embree Thompson, et al.
Journal of Pain and Symptom Management|December 27, 2005
Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancerUrsula A Matulonis, Michael V Seiden, Maria Roche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitorEmily S Robinson, Ursula A Matulonis, Percy Ivy, et al.
Gynecologic Oncology|December 9, 2008
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumorsUrsula A Matulonis, Karen J Krag, Carolyn N Krasner, et al.
Gynecologic Oncology|September 6, 2011
Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levelsChristine M Coticchia, Adam S Curatolo, David Zurakowski, et al.
Molecular Cancer Therapeutics|September 8, 2023
FF-10850, a Novel Liposomal Topotecan Achieves Superior Antitumor Activity via Macrophage- and Ammonia-Mediated Payload Release in the Tumor MicroenvironmentSusumu Shimoyama, Ken Okada, Toshifumi Kimura, et al.
Pageof 24